Preimplantation Genetic Diagnosis (PGD) stands as a cutting-edge procedure in assisted reproductive technology, offering a sophisticated approach to identify chromosomal and genetic abnormalities within embryos derived from an in vitro fertilization (IVF) cycle. This technique plays a crucial role in detecting genetic issues before the embryos are transferred into the womb and implanted, ensuring a more informed and tailored reproductive journey.
At Parens International, we proudly provide PGD services utilizing the advanced Next Generation Sequencing (NGS) method. This approach significantly elevates accuracy and precision, enabling the detection of chromosomal abnormalities and other genetic complications with unparalleled efficacy.
Our comprehensive screening encompasses 24 chromosomes, boasting an exceptional precision rate of 99.9%. This thorough examination serves to exclude a spectrum of conditions, including but not limited to Down’s syndrome, Patau syndrome, Huntington’s disease, Cystic Fibrosis, Edwards syndrome, BRCA, Myotonic dystrophy, and Fragile X syndrome.